Latest news
FDA advisers reject evidence for Duchenne heart therapy - Muscular Dystrophy NewsMuscular Dystrophy News · Tue, 04 Aug 2026 17:04:06 GMTUpdated: Replimune scores win as FDA advisors back melanoma treatment, bucking staff concerns - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTFDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments - Optometry AdvisorOptometry Advisor · Thu, 30 Jul 2026 04:00:00 GMT